RNA Details
                    Disease Name
                    
                    idiopathic pulmonary fibrosis
                    
                    Tissue
                    
                    lung
                    
                    RNA Symbol
                    
                    CCN2
                    
                RNA ID
                    
                    
                    
                RNA Type
                    
                    mRNA
                    
                Alteration Pattern
                    
                    up regulation
                    
                Species
                    
                    homo sapiens
                    
                Detection Methods
                    
                    Data compilation; Statistical analysis etc.
                    
                Target
                    
                    NA
                    
                Pathway
                    
                    NA
                    
                PubMed ID
                    
                    
                    
                    
                    
                Title
                    
                    Transcriptome of Cultured Lung Fibroblasts in Idiopathic Pulmonary Fibrosis: Meta-Analysis of Publically Available Microarray Datasets Reveals Repression of Inflammation and Immunity Pathways
                    
                Year
                    
                     2016
                    
                Function
                    
                    "CTGF, a member of the CCN protein family, is a highly potent extracellular matrix-associated mitogen. In vitro, CTGF induces collagen-1 expression in lung fibroblasts [20]. In vivo, overexpression of CTGF in fibroblasts drives fibrogenesis in multiple organs including the lung [21]. CTGF is overexpressed in IPF, with expression localized to alveolar epithelial cells and fibroblasts [22]. Consistent for a role of CTGF in IPF, a recent open-label uncontrolled study suggested that a monoclonal antibody targeting CTGF, FG-3019, may be beneficial in a subset of IPF patients in terms of lung function decline and imaging-assessed fibrotic changes [23]."